Status:
RECRUITING
Genetics of Cannabis Use Disorder and Cannabinoid Response in Humans
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Schizophrenia
Cannabis Use Disorder
Eligibility:
All Genders
21-60 years
Phase:
PHASE1
Brief Summary
Cannabis is widely used worldwide and is associated with negative outcomes including cannabis use disorder (CanUD), psychosis, and cognitive impairment amongst others. Given the legalization of "recre...
Eligibility Criteria
Inclusion
- Ages 21-60 years old
Exclusion
- Major or unstable medical conditions based on history, the Structured Clinical Interview for DSM-5, collateral information, physical and laboratory examinations, ECG, and vital signs.
- Cannabis naïve individuals
- Positive pregnancy test
Key Trial Info
Start Date :
September 16 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
215 Patients enrolled
Trial Details
Trial ID
NCT06058702
Start Date
September 16 2024
End Date
December 31 2028
Last Update
July 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West Haven Veterans Affairs Medical Center
West Haven, Connecticut, United States, 06516